Lyphe group is a reliable supplier of medical cannabis care and medicine.
Lyphe group has raised $6.3M in total funding. The most recent round was Series A. The last funding was announced in May 2022.
Lyphe group's investors include Sharp Capital Advisors, Leafy Tunnel.
Lyphe group is headquartered in London, United Kingdom.
Lyphe group is a reliable supplier of medical cannabis care and medicine.
Lyphe group is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lyphe group — Funding & Investors." VCBacked, May 23, 2022, https://www.vcbacked.co/company/lyphe-group. Accessed September 30, 2026.
VCBacked. (2022). Lyphe group — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/lyphe-group
{{cite web |title=Lyphe group — Funding & Investors |url=https://www.vcbacked.co/company/lyphe-group |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated